Ho Tung Chemical Balance Sheet Health
Financial Health criteria checks 6/6
Ho Tung Chemical has a total shareholder equity of NT$17.0B and total debt of NT$2.5B, which brings its debt-to-equity ratio to 14.6%. Its total assets and total liabilities are NT$23.9B and NT$6.9B respectively. Ho Tung Chemical's EBIT is NT$901.4M making its interest coverage ratio -5.8. It has cash and short-term investments of NT$8.6B.
Key information
14.6%
Debt to equity ratio
NT$2.49b
Debt
| Interest coverage ratio | -5.8x |
| Cash | NT$8.56b |
| Equity | NT$17.01b |
| Total liabilities | NT$6.93b |
| Total assets | NT$23.94b |
Recent financial health updates
Recent updates
Ho Tung Chemical's (TWSE:1714) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 21
Ho Tung Chemical's (TWSE:1714) Upcoming Dividend Will Be Larger Than Last Year's
Aug 03We Think That There Are Some Issues For Ho Tung Chemical (TWSE:1714) Beyond Its Promising Earnings
May 21Will Ho Tung Chemical's (TPE:1714) Growth In ROCE Persist?
Mar 18Did Ho Tung Chemical's (TPE:1714) Share Price Deserve to Gain 37%?
Feb 11Is Ho Tung Chemical (TPE:1714) A Risky Investment?
Jan 16
Ho Tung Chemical (TPE:1714) Is Growing Earnings But Are They A Good Guide?
Dec 20Will the Promising Trends At Ho Tung Chemical (TPE:1714) Continue?
Nov 24Financial Position Analysis
Short Term Liabilities: 1714's short term assets (NT$14.7B) exceed its short term liabilities (NT$3.9B).
Long Term Liabilities: 1714's short term assets (NT$14.7B) exceed its long term liabilities (NT$3.0B).
Debt to Equity History and Analysis
Debt Level: 1714 has more cash than its total debt.
Reducing Debt: 1714's debt to equity ratio has reduced from 40.9% to 14.6% over the past 5 years.
Debt Coverage: 1714's debt is well covered by operating cash flow (80.9%).
Interest Coverage: 1714 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 20:39 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ho Tung Chemical Corp. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Lan | Citigroup Inc |
| Yucheng Tsai | Masterlink Securities Corp. |
| Gavin Tsai | Polaris Securities Co. Ltd. |